AB PREP — Competitive Intelligence Brief

AB PREP (AB PREP) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Therapeutic vaccine. Area: Infectious Disease.

phase 2 Therapeutic vaccine Infectious Disease Small molecule

Target snapshot

AB PREP (AB PREP) — Long Neck Medical Enterprises. AB PREP is a therapeutic vaccine designed to stimulate an immune response against the SARS-CoV-2 virus.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
AB PREP TARGET	AB PREP	Long Neck Medical Enterprises	phase 2	Therapeutic vaccine
Tat	Tat	Barbara Ensoli, MD	marketed	Therapeutic vaccine	HIV Tat protein
TEP	TEP	Immungenetics AG	marketed	Therapeutic vaccine
HD Vaccine	HD Vaccine	Insight Therapeutics, LLC	marketed	Therapeutic vaccine	Huntingtin protein (HTT)
Mycobacterium Vaccae for Injection	Mycobacterium Vaccae for Injection	Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.	marketed	Immunotherapeutic vaccine
V7	V7	Immunitor LLC	phase 3	Therapeutic vaccine
atherosclerosis vaccine	atherosclerosis vaccine	Immunitor LLC	phase 3	Therapeutic vaccine	Oxidized low-density lipoprotein (oxLDL) and atherosclerotic plaque antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Therapeutic vaccine class)

1. Immunitor LLC · 3 drugs in this class
2. GlaxoSmithKline · 2 drugs in this class
3. Henogen · 2 drugs in this class
4. SK Chemicals Co., Ltd. · 2 drugs in this class
5. Merck Sharp & Dohme LLC · 2 drugs in this class
6. Cytos Biotechnology AG · 2 drugs in this class
7. Clinical Research Organization, Dhaka, Bangladesh · 1 drug in this class
8. Barbara Ensoli, MD · 1 drug in this class
9. Green Cross Corporation · 1 drug in this class
10. Chiang Mai University · 1 drug in this class